Among the different molecular subtypes of BC, human epidermal growth factor receptor 2 (HER2)-positive BC has been demonstrated to exhibit high immunogenicity, with approximately 55% containing high TILs levels in the stroma (4). Here, ERBB2 is linked to breast cancer.